Skip Navigation
Department of Health and Human Services www.hhs.gov
Agency for Healthcare Research Quality www.ahrq.gov
AHRQ Home | Questions? | Contact Us | Site Map | What's New | Browse | Información en español | E-mail UpdatesE-mail Updates
 
Slide Tray
0 slides

Return to Slide Library

Slides

Add Search Results to Slide Tray Search:

"adverse events"

Slides: 1–12 of 164
Add to tray Remove from tray

Outline of This CME Activity

Presentation: Adjunctive Devices for Patients With Acute Coronary Syndromes Undergoing Percutaneous Coronary Intervention
Keywords: outline | comparative effectiveness review | adjunctive devices | percutaneous coronary intervention | outcomes | adverse events
Add to tray Remove from tray

Adjunctive Catheter Aspiration Thrombectomy Versus PCI Alone in Patients With STEMI: Adverse Events

Presentation: Adjunctive Devices for Patients With Acute Coronary Syndromes Undergoing Percutaneous Coronary Intervention
Keywords: adjunctive device | catheter aspiration | percutaneous coronary intervention | PCI | ST-segment elevation myocardial infarction | STEMI | coronary dissection | procedure time
Add to tray Remove from tray

Adjunctive Mechanical Thrombectomy Devices Versus PCI Alone in Patients With STEMI: All Outcomes and Adverse Events

Presentation: Adjunctive Devices for Patients With Acute Coronary Syndromes Undergoing Percutaneous Coronary Intervention
Keywords: adjunctive device | mechanical thrombectomy | percutaneous coronary intervention | PCI | ST-segment elevation myocardial infarction | STEMI | outcomes | adverse events
Add to tray Remove from tray

Adjunctive Mechanical Thrombectomy Devices Versus PCI Alone in Mixed ACS Patients: All Outcomes and Adverse Events

Presentation: Adjunctive Devices for Patients With Acute Coronary Syndromes Undergoing Percutaneous Coronary Intervention
Keywords: adjunctive device | mechanical thrombectomy | percutaneous coronary intervention (PCI) | non–ST-segment elevation myocardial infarction (NSTEMI) | mixed ACS | outcomes | adverse events
Add to tray Remove from tray

Adjunctive Distal Balloon Embolic Protection Devices Versus PCI Alone in Patients With STEMI: Adverse Events

Presentation: Adjunctive Devices for Patients With Acute Coronary Syndromes Undergoing Percutaneous Coronary Intervention
Keywords: adjunctive devices | distal balloon embolic protection | adverse events | coronary perforation | side branch occlusion
Add to tray Remove from tray

Adjunctive Distal Balloon Embolic Protection Devices Versus PCI Alone in Patients With Mixed ACS: All Outcomes and Adverse Events

Presentation: Adjunctive Devices for Patients With Acute Coronary Syndromes Undergoing Percutaneous Coronary Intervention
Keywords: adjunctive devices | distal balloon embolic protection | mixed ACS | outcomes | adverse events
Add to tray Remove from tray

Adjunctive Proximal Balloon Embolic Protection Devices Versus PCI Alone in Patients With STEMI: All Outcomes and Adverse Events

Presentation: Adjunctive Devices for Patients With Acute Coronary Syndromes Undergoing Percutaneous Coronary Intervention
Keywords: adjunctive devices | proximal balloon embolic protection | outcomes | prolonged procedure | adverse events
Add to tray Remove from tray

Overall Conclusions

Presentation: Adjunctive Devices for Patients With Acute Coronary Syndromes Undergoing Percutaneous Coronary Intervention
Keywords: conclusions | ST-segment elevation myocardial infarction | STEMI | percutaneous coronary intervention | PCI | catheter aspiration | mechanical thrombectomy | future research
Add to tray Remove from tray

Rationale for Update

Presentation: Angiotensin-Converting Enzyme Inhibitors (ACEIs), Angiotensin II Receptor Antagonists (ARBs), or Direct Renin Inhibitors (DRI) for Adults With Hypertension
Keywords: systematic review | comparative effectiveness | ACEI | ARB | hypertension | aliskiren | DRI
Add to tray Remove from tray

Evidence on Adverse Effects

Presentation: Angiotensin-Converting Enzyme Inhibitors (ACEIs), Angiotensin II Receptor Antagonists (ARBs), or Direct Renin Inhibitors (DRI) for Adults With Hypertension
Keywords: adverse effects | cough | persistence | withdrawals
Add to tray Remove from tray

Evidence on Adverse Effects: Angioedema

Presentation: Angiotensin-Converting Enzyme Inhibitors (ACEIs), Angiotensin II Receptor Antagonists (ARBs), or Direct Renin Inhibitors (DRI) for Adults With Hypertension
Keywords: serious adverse event | angioedema | ACEIs | DRI
How Individual Studies Consider Applicability. Studies often do not report on factors needed to judge applicability. Increased use of CONSORT diagrams helps, but deficiencies remain. Only a small number of studies are designed with applicability in mind. Most trials are efficacy trials that maximize internal validity at the expense of applicability. CONSORT = Consolidated Standards of Reporting Trials.
Add to tray Remove from tray

How Individual Studies Consider Applicability

Presentation: Assessing Applicability
Keywords: applicability | transparency | efficacy trials | internal validity | outcomes
Pages: [1] 2 3 4 5 6 7 8 9 10 11 12 13 14 Next
 
 
 
 
www.ahrq.gov AHRQ Home | Questions? | Contact AHRQ | Site Map | Accessibility | Privacy Policy | Freedom of Information Act | Disclaimers
U.S. Department of Health & Human Services | The White House | USA.gov: The U.S. Government's Official Web Portal

Agency for Healthcare Research and Quality • 540 Gaither Road Rockville, MD 20850 • Telephone: (301) 427-1364